Search

everythinglearnresearchcommunity

for

Search:↓

Method accurately measures finasteride in tablets using finasteride-BSA interaction.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

The risks of testosterone implants in women outweigh the benefits.

High testosterone increases heart disease risk in women with PCOS.

Spironolactone treatment increases the amount of testosterone available in the body.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Mentha spicata leaves lower testosterone and aggression in female rats.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Testosterone improves mood and thinking skills; finasteride has no effect.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Higher androgen levels are linked to more severe hair growth in hirsute women.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride doesn't affect hormone levels in normal men.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.